Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record, including its eligibility criteria, treatment arms, outcomes, locations, and supporting documents, instead of a 403 error.
    Difference
    100%
    Check dated 2026-11-11T17:23:21.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-28T15:41:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T20:34:46.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T20:21:08.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:44:12.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating access is denied to the record. Several key study documents and related links were removed from the page, reducing publicly available information about the trial.
    Difference
    16%
    Check dated 2026-09-23T21:50:50.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.